Tissue Regeneration Therapeutics (TRT) is a progressive biotechnology company with a focus on the commercial development of our patented Human Umbilical Cord PeriVascular Cell (HUCPVC) platform technology and its TXP cell therapy products.
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | SWK Holdin... | swkhold.co... |